The combination of scientific advances, digital innovations, and novel business models has created opportunities for players across the life sciences market landscape. However, this rapidly changing and increasingly competitive environment has also led to uncertain market access conditions, continued pricing pressure, and disruption from nontraditional market entrants. More than ever, these trends highlight the importance of thinking strategically about where to deploy resources, both for investing in current businesses as well as exploring new pathways for growth.
RNA Advisors can help biopharma companies develop strategies to adapt and win in an evolving global healthcare market. Our team has deep experience in developing valuations and forecasts across a wide variety of therapeutic areas and a number of different stakeholders across the life sciences ecosystem.
From early stage discovery through candidate selection, pre-clinical development, and commercialization, we support clients at every stage of the deal and product development lifecycle.We provide thoughtful perspectives on how to identify and quantify areas of value creation through our engagements, including high-level and deep-drive market assessments, comps analyses, product forecasts, corporate growth strategies, and transaction support for royalty streams, joint ventures, M&A, and licensing deals.RNA Advisors brings together a deep set of analytical capabilities to properly size and assess the potential value of an opportunity, along with years of industry experience to build the supporting narrative to successfully communicate the potential to executives, investors, and other relevant stakeholders.